US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

20.29

-3.3500-14.17%

Post-market: 19.88-0.4100-2.02%19:57 EDT

Volume:895.40K

Turnover:18.84M

Market Cap:75.47M

PE:- -

High:23.03

Open:22.86

Low:19.86

Close:23.64

52wk High:798.00

52wk Low:12.38

Shares:3.72M

Float Shares:3.72M

Volume Ratio:0.91

T/O Rate:24.07%

Dividend:1.98

Dividend Rate:9.76%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health Is Maintained at Hold by TD Cowen

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)

HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise

Hims & Hers GLP-1 subscription fee slightly higher than expected, says BofA

Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership

BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers

Novo Nordisk’s FDA-Approved Glp-1S NOW Available With Hims & Hers

THOMSON REUTERS

Hims & Hers Health Inc - Introduces Weight Loss Membership Starting at $39 First Month, $149 After

THOMSON REUTERS

Hims & Hers Health Inc - Glp-1 Medication Prices Start at $149 per Month

THOMSON REUTERS

Hims & Hers Health Inc - Wegovy Available in Multiple Doses; 7.2 Mg Injection Coming Soon

THOMSON REUTERS

Hims & Hers CFO Oluyemi Okupe disposes of USD 219,000 in common shares

Is It Time To Reassess Hims & Hers Health (HIMS) After Recent Share Price Swings?

Simply Wall St.

Exchange Traded Funds Top 10 Percentage Losers

A high dose of Wegovy helped people lose 21% of their weight. It was just approved.

Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy

Benzinga_recent_news

Hims & Hers Health Chief Legal Officer Soleil Boughton disposed of USD 118,826 of common shares

Hims & Hers Health PAO Irene Becklund disposes of USD 137,000 in common shares

Hims & Hers COO Michael Chi disposes of USD 2.4 million in common shares

BRIEF-Hims & Hers Says We Will Expand Our Platform To Include Wegovy® Pills And Injections And Ozempic® Injections

Hims & Hers: We Will Expand Our Platform to Include Wegovy® Pills and Injections and Ozempic® Injections

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HIMZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":20.29,"timestamp":1774641600000,"preClose":23.64,"halted":0,"volume":895395,"hourTrading":{"tag":"盘后","latestPrice":19.88,"preClose":20.29,"latestTime":"19:57 EDT","volume":17955,"amount":359148.9335,"timestamp":1774655850154,"change":-0.41,"changeRate":-0.020207,"amplitude":0.022706},"delay":0,"changeRate":-0.14170896785109988,"floatShares":3719605,"shares":3719605,"eps":0,"marketStatus":"Market Closed","change":-3.35,"latestTime":"03-27 16:00:00 EDT","open":22.86,"high":23.03,"low":19.86,"amount":18840510.302385,"amplitude":0.134095,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":23.64,"sharesOutstanding":57385000,"nav":23.71,"aum":88191851.47894,"dividendRate":0.097585,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":22.91,"preClose":23.64,"latestTime":"09:28 EDT","volume":13901,"amount":320144.659033,"timestamp":1774618107767,"change":-0.73,"changeRate":-0.03088,"amplitude":0.0478},"postHourTrading":{"tag":"盘后","latestPrice":19.88,"preClose":20.29,"latestTime":"19:57 EDT","volume":17955,"amount":359148.9335,"timestamp":1774655850154,"change":-0.41,"changeRate":-0.020207,"amplitude":0.022706},"volumeRatio":0.9118394386315061,"impliedVol":1.6736,"impliedVolPercentile":0.5433},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":3719605,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9118394386315061,"shares":3719605,"dividePrice":1.98,"high":23.03,"amplitude":0.134095,"preClose":23.64,"low":19.86,"week52Low":12.3816,"pbRate":"--","week52High":798,"institutionHeld":0,"latestPrice":20.29,"eps":0,"divideRate":0.097585,"volume":895395,"delay":0,"ttmEps":0,"open":22.86,"prevYearClose":81.06,"prevWeekClose":26.65,"prevMonthClose":13.608,"prevQuarterClose":81.06,"fiveDayClose":26.65,"twentyDayClose":13.608,"sixtyDayClose":84.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622317876","title":"Hims & Hers Health Is Maintained at Hold by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2622317876","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622317876?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:45","pubTimestamp":1774626300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 11:45 ET (15:45 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","BK4127","HMYY","HIYY","BK4207","BK4196","BK4566","HIMZ","HIMS","BK4585"],"gpt_icon":0},{"id":"2622847110","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622847110?lang=en_us&edition=fundamental","pubTime":"2026-03-27 17:50","pubTimestamp":1774605007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-meiragtx-holdings-mgtx-hims-hers-health-hims-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-meiragtx-holdings-mgtx-hims-hers-health-hims-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","BK4137","MGTX","BK4585","LU0029874061.USD","LU0128526141.USD","SEMHF","BK4139","HIMS","BK4196","BK4588","XBI","LABU","HMYY","HIMY","BK4581","HIMZ","BK4210"],"gpt_icon":0},{"id":"2622936258","title":"HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2622936258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622936258?lang=en_us&edition=fundamental","pubTime":"2026-03-27 02:30","pubTimestamp":1774549854,"startTime":"0","endTime":"0","summary":"Low-cost healthcare services provider Hims & Hers ($HIMS) on Thursday disclosed the availability of approved versions of Novo Nordisk’s ($NVO) GLP-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-slides-after-wegovy-subscription-launch-bofa-sees-31-drop-in-glp-1-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-slides-after-wegovy-subscription-launch-bofa-sees-31-drop-in-glp-1-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","BK4196","BK4144","HIMY","IE00BZ1G4Q59.USD","HIMS","NVOX","LU1093756168.USD","BK4532","BK4588","BK4599","HIMZ","BK4550","LU1093756325.SGD","IE00BKVL7J92.USD","BK4585","BK4590","LU0154236417.USD","NVOH","HIYY","BK4007"],"gpt_icon":0},{"id":"2622860038","title":"Hims & Hers GLP-1 subscription fee slightly higher than expected, says BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2622860038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622860038?lang=en_us&edition=fundamental","pubTime":"2026-03-27 01:30","pubTimestamp":1774546230,"startTime":"0","endTime":"0","summary":"BofA analyst Allen Lutz notes Hims & Hers (HIMS) announced its new membership for branded Wegovy subscriptions through the recently announced NovoC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-glp-1-subscription-fee-slightly-higher-than-expected-says-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-glp-1-subscription-fee-slightly-higher-than-expected-says-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","BK4196","BK4144","HIMY","BK4590","HIMZ","HMYY","HIMS"],"gpt_icon":0},{"id":"2622715862","title":"Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership","url":"https://stock-news.laohu8.com/highlight/detail?id=2622715862","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622715862?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:23","pubTimestamp":1774542180,"startTime":"0","endTime":"0","summary":"Hims & Hers Health will be selling some of Novo Nordisk's GLP-1 medications, including Wegovy.Starting Thursday, eligible customers can access Wegovy pills and injections in several different dosage amounts. Ozempic injection pens, which are approved for treating diabetes but not obesity, also will be available.Prices start as low as $149 a month, Hims & Hers said.The health platform also is introducing a new membership specifically for weight loss. The membership will include support services, 24/7 direct access to providers, personalized nutrition guidance, ongoing clinical check-ins and peer support.Membership starts at $39 for the first month and $149 each month after.Medication costs are separate and may be covered under the customers' HSA and FSA plan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","HIMY","HMYY","IE00BKVL7J92.USD","NVOX","HIYY","BK4599","LU1093756325.SGD","NVOH","BK4007","BK4196","BK4532","LU0154236417.USD","LU1093756168.USD","HIMZ","HIMS","BK4588","BK4585"],"gpt_icon":1},{"id":"2622684862","title":"BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2622684862","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622684862?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:03","pubTimestamp":1774541007,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & HersMarch 26 (Reuters) - Hims & Hers Health Inc HIMS.N:NOVO NORDISK’S FDA-APPROVED GLP-1S NOW AVAILABLE WITH HIMS & ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMY","HIMZ","HMYY","BK4196","HIYY"],"gpt_icon":1},{"id":"2622862557","title":"Novo Nordisk’s FDA-Approved Glp-1S NOW Available With Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2622862557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622862557?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:00","pubTimestamp":1774540804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","HIMZ","HIYY","NVO","HMYY","HIMS","BK4196"],"gpt_icon":0},{"id":"2622862555","title":"Hims & Hers Health Inc - Introduces Weight Loss Membership Starting at $39 First Month, $149 After","url":"https://stock-news.laohu8.com/highlight/detail?id=2622862555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622862555?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:00","pubTimestamp":1774540804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15V:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HIYY","HIMY","HIMS","HIMZ","BK4196"],"gpt_icon":0},{"id":"2622862552","title":"Hims & Hers Health Inc - Glp-1 Medication Prices Start at $149 per Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2622862552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622862552?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:00","pubTimestamp":1774540804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMS","HIMY","HIMZ","HMYY","HIYY"],"gpt_icon":0},{"id":"2622551862","title":"Hims & Hers Health Inc - Wegovy Available in Multiple Doses; 7.2 Mg Injection Coming Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2622551862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622551862?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:00","pubTimestamp":1774540804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HIYY","HIMY","HIMS","HIMZ","BK4196"],"gpt_icon":0},{"id":"2622016009","title":"Hims & Hers CFO Oluyemi Okupe disposes of USD 219,000 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622016009","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622016009?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:10","pubTimestamp":1774390226,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Chief Financial Officer Oluyemi Okupe exercised stock options and acquired 4,489 shares at USD 5.01 on March 20, 2026.Okupe sold 9,217 shares at an average price of USD 23.77 on March 20, 2026.After the transactions, he directly owned 318,789 shares.He also indirectly owned 7,853 shares through a separate property trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL6K5SHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hims & Hers CFO Oluyemi Okupe disposes of USD 219,000 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIYY","HIMY","HIMS","HIMZ","BK4196"],"gpt_icon":1},{"id":"2621096895","title":"Is It Time To Reassess Hims & Hers Health (HIMS) After Recent Share Price Swings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2621096895","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621096895?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:04","pubTimestamp":1774361067,"startTime":"0","endTime":"0","summary":"If you are wondering whether Hims & Hers Health at around US$22.46 is a bargain or a value trap, the key is understanding what the current price actually reflects about the business.\nThe stock has had a mixed run, with a 43.7% return over the past 30 days, set against a 9.7% decline over the past week and a 40.0% decline over the past year.\nRecent coverage has focused on Hims & Hers Health as a telehealth brand serving direct to consumer demand for health and wellness products, as well as on...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-it-time-to-reassess-hims-hers-health-hims-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/is-it-time-to-reassess-hims-hers-health-hims-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIMS","HIYY","HIMZ","BK4196","HMYY","HIMY"],"gpt_icon":1},{"id":"2621752678","title":"Exchange Traded Funds Top 10 Percentage Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2621752678","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621752678?lang=en_us&edition=fundamental","pubTime":"2026-03-21 05:37","pubTimestamp":1774042620,"startTime":"0","endTime":"0","summary":"GrShr 2x Long SMCI Daily  SMCL          1.43  -2.87 -66.74. Defiance Dly Target 2X Lg SMCX          7.25 -14.44 -66.57. YieldMax SMCI Opt Incm    SMCY          5.02  -2.38 -32.16. Defiance Tgt 2X Lg VST    VSTL         27.20  -9.11 -25.09. Defiance Tgt 2x Lg RCAT   RCAX         15.32  -5.03 -24.72. Leverage 2x Lg BE Dly     BEG          30.54  -8.00 -20.77. Direxion Daily KR Bl 3X   KORU        320.98 -76.77 -19.30. Leverage 2x Lg UEC Dly    UECG          6.93  -1.61 -18.87. Defiance Tgt 2X Lg HIMS   HIMZ         26.65  -5.70 -17.62. Leverage 2X Lg USAR Dly   USGG          9.41  -2.01 -17.59","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","BK4585","SMCC","RCAX","VST","LU1861220033.SGD","UECG","VSTL","SMCY","LU0053671581.USD","USGG","BK4588","SMYY","SMCL","SMCI","SMCX","BEG","LU1861215975.USD","BK4543","UEC","SMCZ","BK4170"],"gpt_icon":1},{"id":"2620273128","title":"A high dose of Wegovy helped people lose 21% of their weight. It was just approved.","url":"https://stock-news.laohu8.com/highlight/detail?id=2620273128","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620273128?lang=en_us&edition=fundamental","pubTime":"2026-03-20 02:42","pubTimestamp":1773945720,"startTime":"0","endTime":"0","summary":"Novo Nordisk's 7.2 mg dose of Wegovy will compete against Lilly's GLP-1 injection. Novo Nordisk's high-dose version of Wegovy received approval Thursday from the Food and Drug Administration.A higher dose of Novo Nordisk's GLP-1 injection Wegovy is coming to U.S. pharmacy shelves next month.\"When you increase the dose of [semaglutide] to 7.2 milligram, you get very close on par with tirzepatide,\" Novo Nordisk CEO Mike Doustdar told investors during an earnings call last month. \"And I think it's actually very important that the world gets to know this, and then they can judge that on top of on par weight loss, you have also [cardiovascular] benefit, kidney benefit and then a liver benefit, and then people can pick and choose which option they want.\". The approval of the higher dose of Wegovy aligns with Novo Nordisk's more aggressive stance of late. The company has revealed a handful of hard-charging actions this year aimed at regaining its leading role in the lucrative market for weigh","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"A high dose of Wegovy helped people lose 21% of their weight. It was just approved.","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU0203201768.USD","LU2746668974.SGD","LU2361045086.USD","LU2756315318.SGD","LU0672654240.SGD","LU0061475181.USD","LU2108987350.USD","LU0820561818.USD","LU1720051108.HKD","LU2168564149.EUR","GB00BDT5M118.USD","SG9999014914.USD","BK4534","IE0004445239.USD","IE0004445015.USD","IE00BJT1NW94.SGD","LU0320765059.SGD","LU0154236417.USD","LU2023250504.SGD","LU0256863811.USD","LU2456880835.USD","LU2357305700.SGD","SG9999001176.SGD","LU2264538146.SGD","LU0640476718.USD","LU1057294990.SGD","LU2746668461.USD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0210536198.USD","IE0009355771.USD","LU2211815571.USD","HIMY","SGXZ31699556.SGD","IE00BJLML261.HKD","LU2168564495.EUR","LU2361044865.SGD","IE0002141913.USD","LU0079474960.USD","SG9999017495.SGD","SG9999018857.SGD","LU0820562030.AUD","LU1323610961.USD","LU0006306889.USD","LU1551013425.SGD","LU2750360641.GBP","LU2168563687.JPY","IE0005OL40V9.USD","LU2023251221.USD","LU2089284900.SGD","LU1551013342.USD","LU2089984988.USD","HIYY","LU0708995401.HKD","LU1988902786.USD","IE00B4JS1V06.HKD","IE00BK4W5L77.USD","SG9999018865.SGD","LU0320765992.SGD","LU1720051017.SGD","LU2756315664.SGD","SG9999015978.USD","LU1069344957.HKD","LU2237443382.USD","LU1093756168.USD","LU2023250330.USD","LU0256863902.USD","LU2491050071.SGD","LU2491049909.HKD","LU0353189680.USD","LU1061106388.HKD","IE00B1BXHZ80.USD","LU1629891620.HKD","LU0266013472.USD","SG9999015945.SGD","IE00BN29S564.USD","LU0238689110.USD","LU2111349929.HKD","LU0689472784.USD","LU1868836757.USD","SG9999014880.SGD","LU0683600562.USD","LU0106261372.USD","NVOX","LU2552382215.SGD","BK4516","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU2360106947.USD","ELIL","LU0109394709.USD","LU2236285917.USD","IE00BKVL7J92.USD","LU2168564222.USD","BK4599","LU1868837136.USD","LU0198837287.USD","BK4532","LU1366192091.USD","LU0122379950.USD","LU0417517546.SGD","LU2237438978.USD","LU2471134879.HKD","LU1280957306.USD","LU2471134523.USD","LU1868837300.USD","LU0787776722.HKD","SGXZ51526630.SGD","LU1035775433.USD","LU0097036916.USD","SG9999014906.USD","LU2271345857.HKD","IE00BWXC8680.SGD","SG9999001176.USD","ELIS","LU0471298694.HKD","LU0882574139.USD","HIMZ","LU1974910355.USD","IE00BJJMRX11.SGD","LU0094547139.USD","LU0823434583.USD","IE00B4R5TH58.HKD","LU1127390331.HKD","LU1983299246.USD","LU2087625088.SGD","LU2106854487.HKD","IE00B7KXQ091.USD","LU0158827948.USD","BK4533","LU0114720955.EUR","LU0466842654.USD","SG9999015986.USD","LU1093756325.SGD","LU2028103732.USD","LU1814569148.SGD","LU2237443622.USD","LU1623119135.USD","LU0964807845.USD","LU0203202063.USD","LU0234572021.USD","LU0943347566.SGD","LU2089283258.USD","LU2468319806.SGD","LU2602419157.SGD","BK4196","IE00BKDWB100.SGD","LU2462157665.USD","IE00BKPKM429.USD","LU2265009873.SGD","LLYX","LU2237443978.SGD","LU0323591593.USD","LU0432979614.USD","IE00B775H168.HKD","LU1804176565.USD","LU0096364046.USD","LU1291159041.SGD","LU1548497426.USD","LU0158827781.USD","LU1023059063.AUD","IE00BFSS8Q28.SGD","HMYY","LU1145028129.USD","LU2237443895.HKD","LU2896262040.SGD","LU0353189763.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU0823416689.USD","LU2552382058.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","LU1712237335.SGD","NVOH","SGXZ81514606.USD","LU2237443549.SGD","LU2237443465.HKD","LU1868836914.USD","IE00BK4W5M84.HKD","LU2324357040.USD","SGXZ99366536.SGD","LU0109391861.USD","IE00B1XK9C88.USD","LU2461242641.AUD","LU1232071149.USD","SG9999014898.SGD","LU0786609619.USD","BK4581","LU2112291526.USD","NVO","BK4588","LU0820561909.HKD","IE00BZ1G4Q59.USD","BK4585","LU0058720904.USD","LU0225283273.USD","LU0354030438.USD","LU1267930730.SGD","LU2491050154.USD","LU2552382132.HKD","LU0456855351.SGD","LU0316494557.USD","LU0882574055.USD","LU0471298777.SGD","LU1917777945.USD","LU2063271972.USD","LU2213496289.HKD","LLII","LU2750360997.AUD","BK4007","LU0823434740.USD","LU0385154629.USD","LU2417539215.USD","LU2471134796.USD","IE00BFSS7M15.SGD","IE00B2B36J28.USD","LLYZ","LU1064131342.USD","LU1989771016.USD","LU0354030511.USD","LU0289739699.SGD","LU0889565916.HKD","SG9999013999.USD"],"gpt_icon":1},{"id":"2620278451","title":"Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620278451","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620278451?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:50","pubTimestamp":1773942600,"startTime":"0","endTime":"0","summary":"FDA approves higher-dose Wegovy to boost weight loss in adults with obesity, with rollout expected across U.S. pharmacies in April.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/19/Wegovy.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/19/Wegovy.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/26/03/51363862/novo-nordisk-secures-fda-approval-for-higher-dose-wegovy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/26/03/51363862/novo-nordisk-secures-fda-approval-for-higher-dose-wegovy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0154236417.USD","NVO","HMYY","LU1093756168.USD","NVOH","BK4087","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4196","HIYY","BK4599","BK4532","BK4585","BK4588","HIMZ","NVOX","HIMY","BK4081","BK4007","BK4157"],"gpt_icon":1},{"id":"2620262996","title":"Hims & Hers Health Chief Legal Officer Soleil Boughton disposed of USD 118,826 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262996","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262996?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:19","pubTimestamp":1773865182,"startTime":"0","endTime":"0","summary":"Soleil Boughton, Chief Legal Officer at Hims & Hers Health, reported selling 4,812 shares of Class A common stock on March 17, 2026. The shares were sold at USD 24.69 per share. Following the transaction, Boughton beneficially owned 308,831 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLVSZmp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HMYY","HIMY","BK4196","HIMZ","HIYY"],"gpt_icon":1},{"id":"2620262953","title":"Hims & Hers Health PAO Irene Becklund disposes of USD 137,000 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262953","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262953?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:19","pubTimestamp":1773865157,"startTime":"0","endTime":"0","summary":"Irene Becklund, PAO at Hims & Hers Health, reported selling 5,529 shares of Class A common stock on March 17, 2026. The shares were sold at USD 24.69 per share. Following the transaction, Becklund reported beneficial ownership of 8,752 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9jT8tZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hims & Hers Health PAO Irene Becklund disposes of USD 137,000 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HMYY","HIMY","BK4196","HIMZ","HIYY"],"gpt_icon":1},{"id":"2620962262","title":"Hims & Hers COO Michael Chi disposes of USD 2.4 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620962262","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620962262?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:19","pubTimestamp":1773865146,"startTime":"0","endTime":"0","summary":"Michael Chi, Chief Operating Officer of Hims & Hers Health, reported a sale of 97,289 shares of Class A common stock on March 17, 2026. The shares were sold at USD 24.69 per share. After the transaction, Chi reported beneficial ownership of 407,282 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1jcwrW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMZ","HIMY","HIYY","BK4196","HMYY"],"gpt_icon":1},{"id":"2620256347","title":"BRIEF-Hims & Hers Says We Will Expand Our Platform To Include Wegovy® Pills And Injections And Ozempic® Injections","url":"https://stock-news.laohu8.com/highlight/detail?id=2620256347","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620256347?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:51","pubTimestamp":1773838296,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Says We Will Expand Our Platform To Include Wegovy Pills And Injections And Ozempic InjectionsMarch 18 (Reuters) - Hims & Hers Health Inc HIMS.N:HIMS & HERS: WE WILL EXPAND OUR PLATF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40610U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIYY","HIMS","HIMY","HMYY","HIMZ"],"gpt_icon":1},{"id":"2620025500","title":"Hims & Hers: We Will Expand Our Platform to Include Wegovy® Pills and Injections and Ozempic® Injections","url":"https://stock-news.laohu8.com/highlight/detail?id=2620025500","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620025500?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:50","pubTimestamp":1773838243,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40610U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","BK4196","HIMZ","HIYY","HMYY","HIMS"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":193,"code":"91000000","status":"200"}]}}